M&A Deal Summary

Mymetics Acquires Virosome Biologicals B.V.

On March 9, 2009, Mymetics acquired life science company Virosome Biologicals B.V. from Norwood Immunology for 8M EUR

Acquisition Highlights

This is Mymetics’ 1st transaction in the Life Science sector.
This is Mymetics’ 0th largest (disclosed) transaction.
This is Mymetics’ 1st transaction in the Netherlands.

M&A Deal Summary
Date	2009-03-09
Target	Virosome Biologicals B.V.
Sector	Life Science
Buyer(s)	Mymetics
Sellers(s)	Norwood Immunology
Deal Type	Divestiture
Deal Value	8M EUR

Target

Virosome Biologicals B.V.

Groningen, Netherlands

Virosome Biologicals B.V. is developer of a proprietary vaccine delivery platform (virosome) as well as intranasal influenza and RSV vaccines.

Search 202,196 Deals Now

SEARCH BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Mymetics

Epalinges, Switzerland

Category	Company
Founded	1990
Sector	Life Science
Employees	12
Revenue	2M USD (2014)

DESCRIPTION

Mymetics Corp. is a vaccine company.

DEAL STATS	#
Overall	1 of 1
Sector (Life Science)	1 of 1
Type (Divestiture)	1 of 1
Country (Netherlands)	1 of 1
Year (2009)	1 of 1

Seller(S) 1

SELLER

Norwood Immunology

Melbourne, Australia

Category	Company
Founded	2000
Sector	Life Science

DESCRIPTION

Norwood Immunology Ltd. is a pharmaceutical company.

DEAL STATS	#
Overall	1 of 1
Sector (Life Science)	1 of 1
Type (Divestiture)	1 of 1
Country (Netherlands)	1 of 1
Year (2009)	1 of 1